This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Raloxifene most often prescribed for approved indications. Pharmacoecon. Outcomes News 343, 5 (2001). https://doi.org/10.1007/BF03280755
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03280755